Tokyo Tape
Sign in
← Kringle Pharma

Annual report

4884.TEDINET S100PVFJ
Period2021-10-01 → 2022-09-30
Filed2022-12-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 72
MetricValuePeriodScopeSource row
Revenue¥392m2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥290m2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥468m2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Operating income−¥426m2021-10-01 → 2022-09-30StandaloneOperating income
Operating income−¥358m2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥330m2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥300m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income−¥116m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥302m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥64m2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥330m2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥300m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥332m2021-10-01 → 2022-09-30StandaloneProfit loss
Net income−¥301m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income−¥118m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income−¥302m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income−¥65m2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥3.2bnat 2022-09-30StandaloneAssets
Total assets¥2.6bnat 2021-09-30StandaloneAssets
Total assets¥2.4bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥252mat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥567mat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥420mat 2022-09-30StandaloneLiabilities
Total liabilities¥129mat 2021-09-30StandaloneLiabilities
Net assets / equity¥2.8bnat 2022-09-30StandaloneNet assets
Net assets / equity¥2.5bnat 2021-09-30StandaloneNet assets
Net assets / equity¥2.2bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥216mat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥518mat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥2.1bnat 2021-09-30StandaloneCash and deposits
Cash & equivalents¥2.5bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2020-09-30dStandaloneCash and cash equivalents
Cash & equivalents¥166mat 2019-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥505mat 2018-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥16m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥561m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥146m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥339m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥202m2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥254m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥1,0002017-10-01 → 2018-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥603m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥596m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.1bn2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥199m2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-68.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-72.512020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-106.72019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-290.142018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-62.012017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥517.75at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥578.17at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥599.97at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-570.19at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥-280.06at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio86.8%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.1%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.1%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.9%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.4%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
Shares issued5,380,700at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,334,700at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued182,385at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued52,053at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued52,053at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees12at 2022-09-30StandaloneNumber of employees
Employees11at 2021-09-30StandaloneNumber of employees
Employees9at 2020-09-30dStandaloneNumber of employees
Employees6at 2019-09-30dStandaloneNumber of employees
Employees5at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 787
ItemContextValueUnit
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember602073000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember595904000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember603112000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember34981000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember364525000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember2102538000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember2137520000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember2137520000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember2502046000JPY
Accumulated depreciation buildings and accompanying facilitiesPrior1YearInstant_NonConsolidatedMember-7263000JPY
Accumulated depreciation buildings and accompanying facilitiesCurrentYearInstant_NonConsolidatedMember-7263000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-21082000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember-21082000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember398518000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember533289000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration_NonConsolidatedMember398518000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration_NonConsolidatedMember533289000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2022-12-26
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第21期(自　2021年10月１日　至　2022年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)クリングルファーマ株式会社
Company name in english cover pageFilingDateInstantＫｒｉｎｇｌｅ　Ｐｈａｒｍａ，　Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　安達　喜一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪府茨木市彩都あさぎ七丁目７番15号彩都バイオインキュベータ207
Telephone number address of registered headquarter cover pageFilingDateInstant072-641-8739
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役経営管理部長　村上　浩一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪府茨木市彩都あさぎ七丁目７番15号彩都バイオインキュベータ207
Telephone number nearest place of contact cover pageFilingDateInstant072-641-8739
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役経営管理部長　村上　浩一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE36129
Fund codeFilingDateInstant－
Security codeFilingDateInstant48840
Filer name in japaneseFilingDateInstant
Original text (Japanese)クリングルファーマ株式会社
Filer name in englishFilingDateInstantKringle Pharma, Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2021-10-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2022-09-30
Previous fiscal year start dateFilingDateInstant2020-10-01

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass